ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.
- DOI
- 10.1158/2326-6066.cir-25-1626
- Published
- 2026 Sep 2
- Container
- Cancer immunology research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2326-6066.cir-25-1626,
title = {ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.},
author = {Li B and Wang X and Xie B and Zhong X and Wei P and Lou X and Zhang T and Dong C},
year = {2026},
journal = {Cancer immunology research},
doi = {10.1158/2326-6066.cir-25-1626},
url = {https://doi.org/10.1158/2326-6066.cir-25-1626}
}RIS
TY - JOUR TI - ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy. AU - Li B AU - Wang X AU - Xie B AU - Zhong X AU - Wei P AU - Lou X AU - Zhang T AU - Dong C PY - 2026 JO - Cancer immunology research DO - 10.1158/2326-6066.cir-25-1626 UR - https://doi.org/10.1158/2326-6066.cir-25-1626 ER -
APA
B, L., X, W., B, X., X, Z., P, W., X, L., T, Z., & C, D. (2026). ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.. Cancer immunology research. https://doi.org/10.1158/2326-6066.cir-25-1626
Source records
- pubmed · retrieved 2026-09-26T06:18:12.687Z